PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NTRA vs. PFE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


NTRAPFE
YTD Return114.10%-1.52%
1Y Return195.46%-4.47%
3Y Return (Ann)5.83%-13.54%
5Y Return (Ann)29.51%-1.17%
Sharpe Ratio5.41-0.28
Sortino Ratio5.51-0.24
Omega Ratio1.710.97
Calmar Ratio3.50-0.12
Martin Ratio52.05-0.87
Ulcer Index4.31%7.79%
Daily Std Dev41.47%24.18%
Max Drawdown-77.74%-54.82%
Current Drawdown0.00%-50.04%

Fundamentals


NTRAPFE
Market Cap$16.59B$151.42B
EPS-$2.44$0.75
PEG Ratio0.000.71
Total Revenue (TTM)$1.09B$60.11B
Gross Profit (TTM)$611.63M$36.84B
EBITDA (TTM)-$173.76M$15.48B

Correlation

-0.50.00.51.00.2

The correlation between NTRA and PFE is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

NTRA vs. PFE - Performance Comparison

In the year-to-date period, NTRA achieves a 114.10% return, which is significantly higher than PFE's -1.52% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%100.00%200.00%300.00%400.00%500.00%JuneJulyAugustSeptemberOctoberNovember
489.75%
23.29%
NTRA
PFE

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NTRA vs. PFE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Natera, Inc. (NTRA) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NTRA
Sharpe ratio
The chart of Sharpe ratio for NTRA, currently valued at 5.41, compared to the broader market-4.00-2.000.002.004.005.41
Sortino ratio
The chart of Sortino ratio for NTRA, currently valued at 5.51, compared to the broader market-4.00-2.000.002.004.006.005.51
Omega ratio
The chart of Omega ratio for NTRA, currently valued at 1.71, compared to the broader market0.501.001.502.001.71
Calmar ratio
The chart of Calmar ratio for NTRA, currently valued at 3.50, compared to the broader market0.002.004.006.003.50
Martin ratio
The chart of Martin ratio for NTRA, currently valued at 52.05, compared to the broader market0.0010.0020.0030.0052.05
PFE
Sharpe ratio
The chart of Sharpe ratio for PFE, currently valued at -0.28, compared to the broader market-4.00-2.000.002.004.00-0.28
Sortino ratio
The chart of Sortino ratio for PFE, currently valued at -0.24, compared to the broader market-4.00-2.000.002.004.006.00-0.24
Omega ratio
The chart of Omega ratio for PFE, currently valued at 0.97, compared to the broader market0.501.001.502.000.97
Calmar ratio
The chart of Calmar ratio for PFE, currently valued at -0.12, compared to the broader market0.002.004.006.00-0.12
Martin ratio
The chart of Martin ratio for PFE, currently valued at -0.87, compared to the broader market0.0010.0020.0030.00-0.87

NTRA vs. PFE - Sharpe Ratio Comparison

The current NTRA Sharpe Ratio is 5.41, which is higher than the PFE Sharpe Ratio of -0.28. The chart below compares the historical Sharpe Ratios of NTRA and PFE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-2.000.002.004.006.00JuneJulyAugustSeptemberOctoberNovember
5.41
-0.28
NTRA
PFE

Dividends

NTRA vs. PFE - Dividend Comparison

NTRA has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 6.29%.


TTM20232022202120202019201820172016201520142013
NTRA
Natera, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PFE
Pfizer Inc.
6.29%5.70%3.12%2.64%3.92%3.68%3.12%3.54%3.70%3.48%3.34%3.14%

Drawdowns

NTRA vs. PFE - Drawdown Comparison

The maximum NTRA drawdown since its inception was -77.74%, which is greater than PFE's maximum drawdown of -54.82%. Use the drawdown chart below to compare losses from any high point for NTRA and PFE. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JuneJulyAugustSeptemberOctoberNovember0
-50.04%
NTRA
PFE

Volatility

NTRA vs. PFE - Volatility Comparison

Natera, Inc. (NTRA) has a higher volatility of 10.54% compared to Pfizer Inc. (PFE) at 4.31%. This indicates that NTRA's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%JuneJulyAugustSeptemberOctoberNovember
10.54%
4.31%
NTRA
PFE

Financials

NTRA vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between Natera, Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items